Alterations in U12-Type RNA Splicing in Neutrophils of Systemic Lupus Erythematosus Patients

Overview

This study identifies impaired NADPH oxidase activity in low-density granulocytes from systemic lupus erythematosus (SLE) patients, linked to reduced CYBA expression and U12 intron retention. Transcriptomic analysis reveals broad splicing abnormalities affecting U12-type introns.

Background

Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by immune dysregulation and chronic inflammation, leading to significant morbidity. Aberrant RNA splicing has been implicated in the pathogenesis of SLE, particularly in neutrophils, which play a crucial role in the disease's progression.

Data Highlights

No numerical data or trial data was provided in the source material.

Key Findings

• Impaired NADPH oxidase activity was observed in low-density granulocytes from SLE patients.
• Reduced expression of the CYBA gene was linked to destabilization of Nox enzymes.
• U12 intron retention was identified in neutrophils from SLE patients.
• Transcriptomic analysis revealed widespread splicing abnormalities in SLE low-density granulocytes.
• Minor spliceosome dysfunction may contribute to neutrophil impairment in SLE.

Clinical Implications

Further research is needed to explore the implications of splicing alterations in SLE.

Conclusion

This study identifies U12-type RNA splicing alterations in neutrophils from SLE patients.

Related Resources & Content

1. Clinical Rheumatology, 2025 -- The Role of LncRNA PVT1 in Modulating CD4 + T Cell Imbalance in Systemic Lupus Erythematosus: Findings from Human Studies and MRL/lpr Mouse Models
2. Clinical Rheumatology, 2017 -- Short report: Reduced levels of CD244 (SLAMF4) on monocytes and platelets in individuals diagnosed with systemic lupus erythematosus
3. Clinical Rheumatology, 2025 -- The Role of Serum APRIL, BAFF, and IL-10 Levels in Assessing Disease Activity and Flare Prediction in Systemic Lupus Erythematosus Is Limited
4. Frontiers in Immunology, 2026 -- Characteristics of peripheral blood neutrophil subsets in patients with primary Sjogren’s syndrome based on single-cell RNA sequencing
5. New Lupus SLE Clinical Practice Guideline Released | ACR Convergence 2025 | American College of Rheumatology
6. Long-term Safety and Efficacy of Anifrolumab in Systemic Lupus Erythematosus: A Meta-Analysis of Randomized Controlled Trials, Extension Studies, and Real-World Cohorts | Pharmacology | Karger Publishers
7. Altered Protein Structures and Neoepitopes in Lupus Neutrophils From Dysregulated Splicing of Messenger RNA - PubMed
8. New Lupus SLE Clinical Practice Guideline Released | ACR Convergence 2025 | American College of Rheumatology
9. Long-term Safety and Efficacy of Anifrolumab in Systemic Lupus Erythematosus: A Meta-Analysis of Randomized Controlled Trials, Extension Studies, and Real-World Cohorts | Pharmacology | Karger Publishers
10. Altered Protein Structures and Neoepitopes in Lupus Neutrophils From Dysregulated Splicing of Messenger RNA - PubMed